Franklin Future of Health and Wellness UCITS ETF (GBP) | FRHWRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | - | 3.4 | |
+/-Cat | - | - | - | - | 1.5 | |
+/-B’mrk | - | - | - | - | -1.4 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
Closing Price 16/05/2024 | GBX 2113.50 | |
Day Change | 0.05% | |
Morningstar Category™ | Sector Equity Healthcare | |
Volume | 0 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE0003WEWAX4 | |
Fund Size (Mil) 30/04/2024 | USD 2.52 | |
Share Class Size (Mil) 16/05/2024 | USD 2.67 | |
Ongoing Charge 05/07/2023 | 0.30% |
Investment Objective: Franklin Future of Health and Wellness UCITS ETF (GBP) | FRHW |
The Sub-Fund seeks to provide exposure to companies that are involved in delivering sustainable products and services related to health and wellness globally. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 05/07/2023 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Solactive Sustainable H&W NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Franklin Future of Health and Wellness UCITS ETF (GBP) | FRHW | 16/05/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 3.76 |
Novo Nordisk A/S Class B | Healthcare | 3.42 |
Eli Lilly and Co | Healthcare | 3.38 |
Merck & Co Inc | Healthcare | 3.19 |
Thermo Fisher Scientific Inc | Healthcare | 3.02 |
Increase Decrease New since last portfolio | ||
Franklin Future of Health and Wellness UCITS ETF (GBP) | FRHW |